lanreotide  - Removal Estimates

💊 lanreotide 

lanreotide  Dialyzability By Different Modalities

MW: 1096.33
Protein Binding: 78%%
Vd: 16.1 L/kg

📊 Removal Estimates

Estimates based on drug properties and standard treatment parameters.

🩸

Hemodialysis

10.1 mL/min
Poorly Dialyzable
Minimal removal expected. Half-life: 2 hours (immediate release). No supplementation needed.
Data Used:
✅ protein_binding, molar_mass, mw_factor, vd, vd_factor, half_life
Free fraction: 0.22 Mw factor: 0.85 Vd factor: 0.2 Hl factor: 1 Half life: 2 hours (immediate release) Half life category: Short (1-4h)
🫀

Peritoneal Dialysis

1.1 mL/min
Low PD Clearance
Minimal removal expected. No supplementation needed. Half-life: 2 hours (immediate release).
Data Used:
✅ protein_binding, molar_mass, half_life
Free fraction: 0.22 Half life: 2 hours (immediate release) Half life category: Short (1-4h)
🔄

Plasmapheresis (TPE)

Low Risk
This drug is unlikely to be significantly removed by TPE.
Data Used:
✅ protein_binding, vd, half_life
Half life: 2 hours (immediate release) Half life category: Short (1-4h)
🧪

Hemoadsorption

Low Effectiveness
Poor candidate for hemoperfusion. Drug is distributed in tissues.
Data Used:
✅ vd, half_life
Half life: 2 hours (immediate release) Half life category: Short (1-4h)

📋 Summary of Estimates

Modality Clearance/Value Half-Life Classification Data Quality
Hemodialysis 10.1 mL/min 2 hours (immediate release) Poorly Dialyzable Complete Data
Peritoneal Dialysis 1.1 mL/min 2 hours (immediate release) Low PD Clearance Complete Data
Plasmapheresis (TPE) Low Risk 2 hours (immediate release) N/A Complete Data
Hemoadsorption Low Effectiveness 2 hours (immediate release) N/A Complete Data

📌 Important Notes

Back to Drug Details